Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant gram-negative bacilli

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1678-1684

  Hindler, Janet A ^a   Humphries, Romney M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; POLYSORBATE 80;

ACINETOBACTER BAUMANNII; AGAR DILUTION; AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; INTERMETHOD COMPARISON; KLEBSIELLA PNEUMONIAE; LABORATORY DEVICE; MEASUREMENT ERROR; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SENSITITRE METHOD;

ANTI-BACTERIAL AGENTS; COLISTIN; DIAGNOSTIC ERRORS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

BACILLI (CLASS); NEGIBACTERIA;

EID: 84878487174     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03385-12     Document Type: Article

References (32)

1. Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A. 2010. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int. J. Antimicrob. Agents 35:194-199.
2. Barry AL, Effinger LJ. 1974. Evaluation of two standardized disk methods for testing antimicrobial susceptibility of Pseudomonas aeruginosa and of the Enterobacteriaceae. Antimicrob. Agents Chemother. 6:452-459.
3. Matsen JM, Koepcke MJ, Quie PG. 1969. Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrob. Agents Chemother. 9:445-453.
4. Gales AC, Reis AO, Jones RN. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39:183-190. (Pubitemid 32059588)
5. Hogardt M, Schmoldt S, Gotzfried M, Adler K, Heesemann J. 2004. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J. Antimicrob. Chemother. 54:1057-1061. (Pubitemid 40136741)
6. Moskowitz SM, Garber E, Chen Y, Clock SA, Tabibi S, Miller AK, Doctor M, Saiman L. 2010. Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 65:1416-1423.
7. Tan TY, Ng LS. 2006. Comparison of three standardized disc susceptibility testing methods for colistin. J. Antimicrob. Chemother. 58:864-867. (Pubitemid 44390968)
8. van der Heijden IM, Levin AS, De Pedri EH, Fung L, Rossi F, Duboc G, Barone AA, Costa SF. 2007. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann. Clin. Microbiol. Antimicrob. 6:8.
9. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Tan TY, Ng SY. 2007. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin. Microbiol. Infect. 13:541-544. (Pubitemid 46563506)
11. Karvanen M, Malmber C, Mohamed A, Lagerback P, Friberg LE, Cars O. 2011. Colistin is extensively lost during normal experimental conditions, abstr D-690. Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
12. Clinical and Laboratory Standards Institute. 2012. Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - ninth edition. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Albur M, Noel A, Bowker K, MacGowan A. 2012. Colistin MIC testing: the effect of different types of microtitre trays and surfactant Tween 80 in broth microdilution method, abstr D-763, p 96. Abstr 52nd Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
14. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18:268-281.
15. Clinical and Laboratory Standards Institute. 2008. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline - third edition. CLSI document M23-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
16. Brown MR, Winsley BE. 1971. Synergism between polymyxin and polysorbate 80 against Pseudomonas aeruginosa. J. Gen. Microbiol. 68:367-373.
17. Sader HS, Moet GJ, Rhomberg PR, Fritsche TR, Jones RN. 2006. Influence of surfactant (polysorbate 80) on susceptibility testing results for the polymyxins using broth microdilution methods, abstr C-140, Abstr. 106th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
18. Sader HS, Rhomberg PR, Flamm RK, Jones RN. 2012. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin. Diagn. Microbiol. Infect. Dis. 74:412-414.
19. Rennie RP, Koeth L, Jones RN, Fritsche TR, Knapp CC, Killian SB, Goldstein BP. 2007. Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent. J. Clin. Microbiol. 45:3151-3154. (Pubitemid 47585633)
20. Bolstrom A, Karlsson P, Ho H, Sader HS, Jones R. 2005. Validation of Etest colistin and polymyxin B against the CLSI reference methods using 413 strains with a wide susceptibility range. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
21. Lo-Ten-Foe JR, de Smet A, Diederen BMW, Kluytmans J, van Keulen PHJ. 2007. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob. Agents Chemother. 51:3726-3730. (Pubitemid 47519365)
22. Michalopoulos A, Falagas ME. 2011. Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann. Intensive Care 1:1-6.
23. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L. 2006. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:2946-2950. (Pubitemid 44396396)
24. Hawley JS, Murray CK, Jorgensen JH. 2008. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob. Agents Chemother. 52:351-352.
25. Meletis G, Tzampaz E, Sianou E, Tzavaras I, Sofianou D. 2011. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 66:946-947.
26. Gales AC, Jones RN, Sader HS. 2011. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J. Antimicrob. Chemother. 66:2070-2074.
27. Sader HS, Farrell DJ, Jones RN. 2011. Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009). Int. J. Antimicrob. Agents 37:174-175.
28. KPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob. Agents Chemother. 54:526-529.
29. Galani I, Kontopidou F, Souli M, Rekatsina PD, Koratzanis E, Deliolanis J, Giamarellou H. 2008. Colistin susceptibility testing by Etest and disk diffusion methods. Int. J. Antimicrob. Agents 31:434-439.
30. Galani L, Ioannidis K, Plakias G, Karaiskos I, Baziaka F, Vakalis N, Giamarellou H. 2011. Emergence of colistin resistance in Klebsiella pneumoniae runs in parallel with extensive use of colistin treatment, abstr K-1885. Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
31. Maalej S, Meziou MR, Rhimi FM, Hammami A. 2011. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae. Lett. Appl. Microbiol. 53:546-551.
32. Urban C, Tiruvury H, Mariano N, Colon-Urban R, Rahal JJ. 2011. Polymyxin-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 55:388-389.